Sulfamerazine
DERMATOLOGICALS
Also known as: cremomerazine, methylsulfazine, metilsulfadiazin, sulfamerazin, sulphamerazine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Sulfamerazine is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1949. DrugCentral lists 1 molecular target, including folP.
- Approval status: ofm (first approved 1949 by the FDA).
- Molecular targets: folP (1 listed in DrugCentral).
- ATC code: D06BA06 (Sulfonamides).
- Molecular formula: C11H12N4O2S; molecular weight 264.30 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (8)
- Anemia due to enzyme deficiency
- Breastfeeding (mother)
- Disease of blood AND/OR blood-forming organ
- Disease of liver
- Kidney disease
- Megaloblastic anemia due to folate deficiency
- Porphyria
- Third trimester pregnancy
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Dihydropteroate synthase | folP | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1949-08-16 | FDA | — | LEDERLE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
D06BA06 | DERMATOLOGICALS › ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE › CHEMOTHERAPEUTICS FOR TOPICAL USE › Sulfonamides |
J01ED07 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Long-acting sulfonamides |
J01EE07 | ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › SULFONAMIDES AND TRIMETHOPRIM › Combinations of sulfonamides and trimethoprim, incl. derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Sulfamerazine is on its molecule page.
| Molecular formula | C11H12N4O2S |
|---|---|
| Molecular weight | 264.30 g/mol |
| CAS number | 127-79-7 |
| InChIKey | QPPBRPIAZZHUNT-UHFFFAOYSA-N |
| PubChem CID | 5325 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Sulfamerazine work?
Its molecular targets in DrugCentral include folP (inhibitor).
When was Sulfamerazine first approved?
Sulfamerazine was first approved by the FDA in 1949.
What is the chemical formula of Sulfamerazine?
Sulfamerazine has the molecular formula C11H12N4O2S and a molecular weight of 264.30 g/mol.
Browse: all drugs starting with S · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2510 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL438 — compound record and bioactivity
- PubChem CID 5325 — chemical identifiers
- DrugBank DB01581 — drug record
- FDA UNII UR1SAB295F — substance identity
- DailyMed: FDA labels for Sulfamerazine — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.